DORAMECTIN
Chemical Name | (1'R,2S,4'S,5S,6R,8'R,10'E,12'R,13'S,14'E,20'R,21'R,24'S)-6-cyclohexyl-21',24'-dihyd-roxy-12'-{[(2R,4S,5S,6S)-5-{[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl]oxy}-5,11',13',22'-tetramethyl-5,6-dihydro-3',7',19'-trioxaspiro[pyran-2,6'-tetracyclo[15.6.1.14,8.020,24]pentacosane]-10',14',16',22'-tetraen-2'-one |
CAS Number | 117704-25-3 |
Molecular Formula | C50H74O14 |
Molecular Weight | 899.11 |
Molecular Structure | |
Packing | 5kg/TIN |
Capacity | 1MT/MONTH |
Storage | The final product is packaged in a 2-ply polyethylene bag, vacuumized and heat-sealed, and sealed in aluminum foil bag, then sealed in aluminum tin. The containers were stored at 5± 3°C. |
Application | DORAMECTIN is used for the treatment and control of internal parasitosis (gastrointestinal and pulmonary nematodes), ticks and mange (and other ectoparasites). |
SPECIFICATION
Items | Specification |
Appearance | White crystalline powder |
Identification | Positive |
Water | ≤3.0% |
Heavy Metals | ≤20PPM |
Sulphated Ash | ≤0.1% |
Related Substances | |
Abamectin | ≤2.0% |
Total Impurities | ≤10.0% |
Residual Solvent | |
Ethanol | ≤30000ppm |
Acetone | ≤5000ppm |
BHT | ≤2000ppm |
Assay | ≥90.0% calculated on the anhydrous and solvent- free basis |
Standard | Factory Standard |